Page last updated: 2024-09-03

rubimaillin and Carcinoma, Pancreatic Ductal

rubimaillin has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, X; Huang, S; Li, H; Li, L; Lin, G; Qiao, J; Sun, W; Yang, S; Zhang, H	1

Other Studies

1 other study(ies) available for rubimaillin and Carcinoma, Pancreatic Ductal

Article	Year
Discovery of Potent Small-Molecule SIRT6 Activators: Structure-Activity Relationship and Anti-Pancreatic Ductal Adenocarcinoma Activity. Journal of medicinal chemistry, 2020, 09-24, Volume: 63, Issue:18 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enzyme Activators; Female; G2 Phase Cell Cycle Checkpoints; Humans; Mice, Inbred BALB C; Molecular Docking Simulation; Molecular Structure; Pancreatic Neoplasms; Protein Binding; Quinolines; Sirtuins; Structure-Activity Relationship; Xenograft Model Antitumor Assays	2020

Article

Year

Discovery of Potent Small-Molecule SIRT6 Activators: Structure-Activity Relationship and Anti-Pancreatic Ductal Adenocarcinoma Activity.

Journal of medicinal chemistry, 2020, 09-24, Volume: 63, Issue:18

Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enzyme Activators; Female; G2 Phase Cell Cycle Checkpoints; Humans; Mice, Inbred BALB C; Molecular Docking Simulation; Molecular Structure; Pancreatic Neoplasms; Protein Binding; Quinolines; Sirtuins; Structure-Activity Relationship; Xenograft Model Antitumor Assays

2020